Low detectable PSA after prostatectomy – watch or treat? | THE "NEW" PROSTATE CANCER INFOLINK
Can local treatment prolong the sensitivity of metastatic prostate cancer to androgen deprivation or even prevent castration resistance? | SpringerLink
The natural history of a delayed detectable PSA after radical prostatectomy | Prostate Cancer and Prostatic Diseases
The comparison of prostate volume and PSA density between the Asian and... | Download Table
Reevaluating PSA Testing Rates in the PLCO Trial | NEJM
Biomedicines | Free Full-Text | Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in
Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil | Radiation Oncology | Full Text
Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting | PLOS ONE
![PDF] The Effect of Cystoscopy on PSA Levels in Patients with Urologic Diseases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/06080c014f6ab802fe6c32846350e5cfbba53484/3-Table1-1.png "PDF] The Effect of Cystoscopy on PSA Levels in Patients with Urologic Diseases | Semantic Scholar")
PDF] The Effect of Cystoscopy on PSA Levels in Patients with Urologic Diseases | Semantic Scholar
Primary Care of the Prostate Cancer Survivor | AAFP
Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value | PLOS ONE
Cutoff value of time to prostate-specific antigen nadir is inversely correlated with disease progression in advanced prostate cancer in: Endocrine-Related Cancer Volume 19 Issue 5 (2012)
Comparison of PSA-density of the transition zone and whole gland for risk stratification of men with suspected prostate cancer: A retrospective MRI-cohort study - ScienceDirect
Day 2,701 — PSA Test Time - Cancer Health
Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
xmlinkhub
Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen | Journal of Urology
Cancers | Free Full-Text | Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction
SciELO - Brasil - Biochemical recurrence after radical prostatectomy: is the disease or the surgeon to blame? Biochemical recurrence after radical prostatectomy: is the disease or the surgeon to blame?
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value | PLOS ONE
